Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models

The lack of effective treatment modalities is a major problem in pancreatic cancer (PCa), a devastating malignancy that is nearly universally driven by the “undruggable” KRAS and TP53 cancer genes. Poor tumor tissue penetration is the major source of resistance in pancreatic cancer where chemotherap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Bobrov, Egor, Skobeleva, Natalia, Restifo, Diana, Beglyarova, Natalya, Cai, Kathy Q., Handorf, Elizabeth, Campbell, Kerry, Proia, David A., Khazak, Vladimir, Golemis, Erica A., Astsaturov, Igor
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354841/
https://ncbi.nlm.nih.gov/pubmed/27779106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12642
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars